Electrophoresis Market Analysis & Forecast: 2025-2032

Electrophoresis Market is estimated to be valued at USD 3.43 Bn in 2025 and is expected to reach USD 5.02 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032. The increasing application of electrophoresis in cancer research and the increasing collaboration between key market players and research organizations are expected to drive market growth.

Analysts’ Views on the Global Electrophoresis Market:

Technological advancements in electrophoresis instruments, such as the availability of automated systems over manually operated systems and the availability of rapid test results, are expected to fuel market growth. Moreover, the shift towards genomics and proteomics has led to the technological advancement of electrophoresis instruments for use during drug discovery. Thus, it is expected to show significant growth opportunities for the market over the forecast period.

Figure 1. Global Electrophoresis Market Share (%), By Product Type, 2025

To learn more about this report, Request sample copy

Global Electrophoresis Market– Drivers

• Increasing application of electrophoresis in cancer research: The protein electrophoresis test is often used to find abnormal substances called M proteins. The presence of M proteins can be a sign of a type of cancer called myeloma, multiple myeloma, and others. Thus, an increase in the number of cancer cases is expected to increase the use of electrophoresis technology for cancer detection and research and development for its cure. For instance, according to the World Health Organization (WHO), on July 12, 2023, there were more than 685,000 deaths associated with breast cancer globally in 2020.

• Increasing collaboration between key market players and research organizations: A rise in the number of strategies, such as collaboration between key market players and several research organizations and universities, so as to conduct research regarding genetic diseases, is also expected to drive market growth for the forecast period. For instance, on August 7, 2023, Pacific Biosciences of California, Inc., an U.S.-based biotechnology company, and GeneDx, an U.S.-based genetic testing company, jointly announced that they have collaborated with the University of Washington to study the capabilities of HiFi long-read whole genome sequencing (WGS) to increase diagnostic rates in pediatric patients with genetic conditions.

Figure 2. Global Electrophoresis Market Share (%), By Region, 2025

To learn more about this report, Request sample copy

Global Electrophoresis Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global electrophoresis market over the forecast period. North America is estimated to hold 33.5% of the market share in 2025, and this is attributed to the presence of major players such as Thermo Fisher Scientific Inc., Sigma-Aldrich Corporation, ACTGene, Beckman Coulter, Merck Group, and others, which contribute to the development of the electrophoresis market in North America.

Global Electrophoresis Market– Impact of Coronavirus (COVID-19) Pandemic

• Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.
• COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, are facing problems with the transportation of things from one place to another.
• However, the COVID-19 pandemic had a positive impact on the global emectrophoresis market, as electrophoresis techniques such as agarose gel electrophoresis in combination with RT-PCR (reverse transcription-polymerase chain reaction) had major applications in the detection of COVID-19 viral proteins and nucleic acids. For instance, according to an article published in Springer Nature, an open-access scientific and medical journal, in November 2021, the detection of SARS-CoV-2 using the two-step end-point RT-PCR method, followed by agarose gel electrophoresis, is a reliable alternative to the gold standard RT-qPCR technique and has an accuracy of 95.8% in the detection of a COVID-19 positive sample.

Global Electrophoresis Market Segmentation:

The global electrophoresis market report is segmented into product type, application, end user and region.

• By product type, the market is segmented into instruments, kits and reagents, and accessories. Out of which, instruments is expected to hold a dominant position in the global electrophoresis market during the forecast period, and this is attributed to the increasing product launches by key market players.
• By application, the market is segmented into estimation of DNA molecule, analysis of PCR product, forensic science, protein and antibody interaction, clinical pathology analysis. Out of which, forensic science is expected to dominate the market over the forecast period, and this is attributed to increased application of electrophoresis in the determination of DNA of victims in forensic science.
• By end user, the market is segmented into pharmaceutical and biotechnology companies, diagnostic labs, others (CROs, CMOs, Academic Institutes, etc.). Out of which, pharmaceutical and biotechnology companies is expected to dominate the market over the forecast period, and this is attributed to the increased use of electrophoresis techniques by the pharmaceutical and biotechnology companies in drug discovery.

Among all the segmentation, the product type segment has the highest potential, and this is attributed to increasing product launches by key market players.

Global Electrophoresis Market- Cross Sectional Analysis:

In the end user segment, pharmaceutical and biotechnology companies held a dominant position in the North America region due to an increase in the amount of funding received by key market players. For instance, on August 1, 2023, Penn Medicine, an U.S.-based healthcare organization, announced that it had received funding of US$ 26 million from the National Institutes of Health (NIH), a U.S. government organization, to develop treatments for rare incurable genetic diseases. This funding will be used to research and development activities using techniques such as PCR, electrophoresis, for isolation and to study DNA fragments so as to develop a cure for genetic diseases.

Global Electrophoresis Market: Key Developments

• In September 2020, Promega Corporation, an U.S.-based manufacturer of enzymes and instruments for biotechnology and molecular biology purposes, announced the launch of its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System. The Spectrum Compact CE System is an integrated DNA analysis instrument that enables life scientists in laboratories of all sizes to perform Sanger sequencing and fragment analysis at the bench.
• On May 18, 2023, SCIEX, a U.S.-based medical instruments manufacturer, announced that it has launched the BioPhase 8800 system, a multi-capillary electrophoresis system that enables biopharma scientists to run multiple samples in parallel, accelerating the development and execution of sensitive, high-throughput analytical methods.
• In September 2022, miniPCR bio, a manufacturer of scientific tools for educators and researchers, announced the launch of the Bandit STEM Electrophoresis Kit, an educational electrophoresis system, for students

Global Electrophoresis Market: Key Trends

• Technological advancement in electrophoresis techniques: Recent technological advancements in electrophoresis techniques, such as the advancement of automated electrophoresis systems over manual electrophoresis systems, are expected to drive market growth for the forecast period. Moreover, according to an article published in Wiley Online Library, an open-access medical journal, in August 2022, researchers from the University of South Carolina have developed microchip electrophoresis techniques which is a miniature version of traditional electrophoresis instruments and has better sensitivity in terms of separation than mass spectrometry.

Global Electrophoresis Market: Restraint

• High cost of electrophoresis instruments: The factor that can act as an anchor to the growth of the global electrophoresis market is the high cost of electrophoresis instruments. For instance, the price of the Spectrum Compact CE System, which is manufactured by Promega Corporation, is around US$ 14,467. Thus, such a high cost of instruments can hamper market growth. As a result, key market players must focus on launching more economical eclectrophoresis instruments.

Global Electrophoresis Market - Key Players

Major players operating in the global electrophoresis market include Cleaver Scientific, Thermo Fisher Scientific Inc., Sigma-Aldrich Corporation, ACTGene, Beckman Coulter, BiOptic, Merck Group, Hoefer, Lumex Instruments, Spectroline, Analytic Jena, Bio- Rad laboratories, Cytiva UK limited, Kewaunee Scientific, Prince Technology, Lumex Instruments, Agilent Technologies, and Syngene

*Definition: Electrophoresis is a laboratory technique used to separate DNA, RNA or protein molecules based on their size and electrical charge. An electric current is used to move the molecules through a gel or other matrix.